Can Online Psychiatrist Prescribe Medication

The Quick Answer: Yes, Online Psychiatrists Can Prescribe Medication

Online psychiatrists who are licensed medical doctors (MDs or DOs) can absolutely prescribe medications, including psychiatric medications and controlled substances. This is a legal, regulated, and increasingly common practice with strong research support for safety and efficacy.

The ability to prescribe depends on:

• Provider credentials: The clinician must be a licensed medical doctor (MD/DO) or in some states, an advanced practice provider (NP/PA) with prescribing authority
• State licensing: The psychiatrist must hold a valid medical license in your state
• DEA registration: For controlled substances, the psychiatrist must have current DEA registration and comply with federal regulations
• Proper evaluation: The psychiatrist must conduct adequate clinical assessment before prescribing (no "instant prescriptions" without proper evaluation)
• Legal requirements: Some medications have specific regulatory requirements (e.g., controlled substances, buprenorphine)

At KwikPsych, Dr. Monika Thangada, M.D., is licensed in Texas, California, and Missouri, with full DEA registration to prescribe all FDA-approved psychiatric medications, including controlled substances when clinically appropriate.

Which Medications Can Be Prescribed Online?

The short answer: virtually all psychiatric medications can be prescribed via telehealth for patients who have been properly evaluated. Here's the breakdown by medication class:

Clear Yes—Prescribed on First Telehealth Visit

• SSRIs (Selective Serotonin Reuptake Inhibitors): Sertraline, paroxetine, fluoxetine, citalopram, escitalopram, etc.
• SNRIs (Serotonin-Norepinephrine Reuptake Inhibitors): Venlafaxine, duloxetine, desvenlafaxine
• Other antidepressants: Bupropion, mirtazapine, trazodone, buspirone
• Benzodiazepines for acute anxiety: Lorazepam, alprazolam (short-term, with appropriate monitoring)
• Sleep aids: Trazodone, melatonin, zolpidem (with evaluation)
• Mood stabilizers (non-controlled): Valproate, lamotrigine, topiramate
• Atypical antipsychotics: Quetiapine, aripiprazole, lurasidone, risperidone (with monitoring)

Usually Yes—May Require Baseline Labs or Additional Information

• Lithium: Requires baseline kidney/thyroid labs; ongoing blood level monitoring. Can be started via telehealth with lab arrangement
• Stimulants (ADHD medications): Methylphenidate, amphetamine-based medications—yes, can be prescribed via telehealth in most states with proper evaluation and monitoring
• Beta-blockers for anxiety: Propranolol (may require baseline blood pressure/heart rate assessment)
• Antabuse (disulfiram) for alcohol dependence: Can be prescribed via telehealth with appropriate patient assessment and consent

Controlled Substances—Yes, With DEA Compliance

• Schedule II stimulants: Adderall, Ritalin, Concerta (ADHD), and other amphetamine/methylphenidate formulations
• Schedule III-IV benzodiazepines: Alprazolam, lorazepam, clonazepam (anxiety/panic)
• Other Schedule III-IV controlled medications: Butalbital combinations, some sleep aids
• Buprenorphine (Schedule III): For opioid use disorder (specific federal regulations apply; can be telehealth-prescribed under DATA-waived providers)

Usually Not Prescribed on First Telehealth Visit (May Need Follow-Up)

• Antipsychotics requiring monitoring: Clozapine (requires regular white blood cell counts; very rare to start via telehealth)
• Some beta-blockers: For cardiac indications (likely requires in-person cardiology or primary care involvement)

Not Appropriate for Online/Telehealth Prescription

• Medications requiring in-office procedures: Medications requiring intramuscular injection, IV infusion, or in-office monitoring equipment
• Medications for acute emergency conditions: Acute cardiac medications, emergency medications for psychiatric crisis requiring in-person evaluation

Antidepressants: SSRIs and SNRIs Online

Can I Get an SSRI Prescription from an Online Psychiatrist?

Yes, absolutely. SSRIs and SNRIs are among the most commonly prescribed psychiatric medications via telehealth. They are safe, well-tolerated, and appropriate for first-visit prescription following a proper psychiatric evaluation.

The Evaluation Process

On your first video consultation with an online psychiatrist, you can expect:

• Symptom assessment: Detailed discussion of your depression, anxiety, mood patterns, suicidal ideation (if relevant)
• Medical history: Current medications, medical conditions, allergies, family psychiatric history
• Prior medication trials: What antidepressants have you tried? Response? Side effects?
• Substance use and alcohol: Current use, history of dependence
• Physical health: Baseline blood pressure, weight, general health status
• Risk assessment: If depression is present, assessment of suicidal thoughts or self-harm urges

Based on this evaluation, the psychiatrist will recommend a specific SSRI or SNRI, explain how it works, discuss potential side effects, and provide dosing instructions.

Which SSRI or SNRI Will My Online Psychiatrist Prescribe?

The choice depends on:

• Your specific symptoms: Some SSRIs are better for anxiety; others for fatigue-prominent depression
• Side effect profile: Some SSRIs cause activation; others are sedating. Choice depends on your baseline symptoms
• Medical history: Certain medications may interact with your current drugs or medical conditions
• Prior response: If you've tried SSRIs before, your psychiatrist will consider what worked or didn't work
• Pregnancy/nursing: Some SSRIs are preferred during pregnancy; others are avoided

Common SSRIs prescribed via telehealth: Sertraline (Zoloft), escitalopram (Lexapro), paroxetine (Paxil), citalopram (Celexa), fluoxetine (Prozac)
Common SNRIs: Venlafaxine (Effexor), duloxetine (Cymbalta)

Starting, Adjusting, and Managing SSRI/SNRI via Telehealth

Your psychiatrist will prescribe a starting dose (often low, increasing gradually to minimize side effects). You'll have follow-up appointments—typically 2-4 weeks after starting—to assess response and tolerability. If you experience side effects or inadequate response, your psychiatrist will adjust the dose or switch medications. This entire process works effectively via telehealth with regular video check-ins.

Mood Stabilizers and Other Non-Controlled Medications

Mood Stabilizers for Bipolar Disorder and Depression

Mood stabilizers—medications like valproate (Depakote), lamotrigine (Lamictal), and topiramate (Topamax)—can absolutely be prescribed via telehealth. Some require baseline lab work before starting.

Lithium: Special Considerations

Lithium can be prescribed via telehealth, but requires careful setup:

• Baseline labs required before starting: kidney function (creatinine, BUN), thyroid function (TSH), pregnancy test if applicable
• Your online psychiatrist will request these labs before your appointment or during initial evaluation
• Once started, you'll need periodic blood tests (typically every 3-6 months) to monitor lithium levels and organ function
• These labs can be done locally at any lab facility (Quest, LabCorp, hospital, primary care office)
• You report results to your psychiatrist; they adjust dosing as needed

Many telehealth practices work seamlessly with local labs to arrange blood work, so you don't need to travel to the psychiatrist's office for monitoring.

Other Mood Stabilizers

Valproate/divalproex (Depakote): Requires baseline liver function tests and periodic monitoring. Can be started via telehealth.

Lamotrigine (Lamictal): Generally safe to start without labs; no ongoing monitoring required. Good candidate for first-visit telehealth prescription.

Topiramate (Topamax): Safe to start via telehealth; minimal monitoring.

Controlled Substances Via Telehealth: What's Allowed

Can Online Psychiatrists Prescribe Controlled Substances?

Yes—but with regulatory requirements and safeguards. This is a common question, and the answer has evolved significantly with federal telemedicine flexibilities extended through 2025.

Schedule II Stimulants (ADHD Medications)

Schedule II controlled substances—including Adderall (amphetamine), Ritalin/Concerta (methylphenidate), and other ADHD stimulants—can be prescribed via telehealth by psychiatrists with DEA registration. The process includes:

• Comprehensive evaluation: ADHD assessment, symptom history, prior treatment attempts, medical history, baseline vital signs
• Risk stratification: Assessment for stimulant contraindications (cardiac issues, uncontrolled hypertension, substance use disorder history)
• First prescription options: Under current DEA telemedicine flexibilities (extended through 2025), a qualified psychiatrist can prescribe Schedule II stimulants on the first telehealth visit with proper evaluation
• Ongoing monitoring: Regular follow-ups to assess response, side effects, and continued appropriateness of medication
• Refill protocols: Controlled substance prescriptions require specific handling; most can be sent electronically to pharmacy via DEA-compliant channels

Schedule III-IV Benzodiazepines

Benzodiazepines (alprazolam/Xanax, lorazepam/Ativan, clonazepam/Klonopin) can be prescribed via telehealth by psychiatrists with DEA registration. These are commonly prescribed for anxiety and panic disorder. Your psychiatrist will:

• Assess anxiety severity, prior medication trials
• Evaluate for contraindications (respiratory disease, substance use disorder)
• Prescribe at appropriate dose with clear monitoring plan
• Recommend using the lowest effective dose for the shortest duration
• Plan for periodic review and potential deprescribing

Other Schedule III-IV Controlled Substances

Other controlled psychiatric medications—including certain sleep aids (zaleplon/Sonata) and other agents—can similarly be prescribed via telehealth with proper evaluation and DEA compliance.

Schedule II vs. Other Controlled Substances: Prescription Differences

Schedule II medications (stimulants, some opioids) have stricter rules: prescriptions must be signed and may require specific handling. However, DEA has authorized electronic prescribing of Schedule II medications (e-prescribing) from DEA-registered providers, which streamlines the process.

Schedule III-IV medications have fewer restrictions and can be prescribed and refilled more flexibly via telehealth.

Understanding the Ryan Haight Act and Telemedicine Flexibilities

What Is the Ryan Haight Act?

The Ryan Haight Online Pharmacy Consumer Protection Act (2008) is federal law that, under normal circumstances, requires prescribers to conduct at least one in-person medical evaluation with a patient before prescribing a controlled substance. This law was designed to prevent prescription drug abuse through online pharmacies.

The Act's requirement: "Prior to issuing a prescription, the practitioner shall conduct at least one in-person medical evaluation of the patient."

COVID-19 Temporary Flexibilities: What Changed?

During the COVID-19 emergency, the DEA granted temporary flexibilities to this requirement, allowing licensed prescribers to prescribe controlled substances via telehealth without a prior in-person visit. These flexibilities have been extended multiple times and are currently authorized through December 31, 2025.

This means, as of March 2026, the situation is:

• If flexibilities remain extended past December 2025: Controlled substances can continue to be prescribed via telehealth without prior in-person visit
• If flexibilities expire: The original Ryan Haight requirement returns: at least one in-person visit before controlled substance prescription

For non-controlled medications (SSRIs, mood stabilizers, etc.): These are NOT subject to the Ryan Haight Act and can be prescribed via telehealth without any in-person requirement.

What KwikPsych Offers

At KwikPsych, Dr. Thangada is DEA-registered and complies with all current federal telemedicine regulations. She can prescribe both controlled and non-controlled psychiatric medications via secure video consultation in accordance with all applicable state and federal laws. Patients in Texas receive care fully compliant with Texas Medical Board regulations and federal DEA guidelines.

Key Point: Evaluation Still Required

Even though the Ryan Haight Act's in-person requirement has temporary flexibilities, proper psychiatric evaluation is still absolutely required before any prescription. Online psychiatrists do not prescribe medications without thorough assessment. "Instant prescriptions" without evaluation are not legitimate telehealth practice and violate professional standards.

How the Telehealth Medication Prescription Process Works

Step 1: Schedule Your Consultation

You request an appointment at KwikPsych via our online portal or by calling 737-367-1230. You select a telehealth video appointment time.

Step 2: Pre-Appointment Information

Before your appointment, you complete an intake form including:

• Current symptoms and psychiatric history
• Current medications and supplements
• Medical conditions and allergies
• Family history of mental illness
• Substance use history
• Prior psychiatric treatment and medication trials

Step 3: Video Consultation

Dr. Thangada meets with you via secure, HIPAA-compliant video. This initial evaluation typically lasts 45-60 minutes and includes:

• Detailed psychiatric interview
• Symptom assessment using validated scales (if indicated)
• Medical and medication history review
• Risk assessment (suicidal ideation, self-harm, substance use)
• Discussion of treatment options and goals
• If medication is recommended: explanation of the drug, expected benefits, potential side effects, dosing plan

Step 4: Prescription Issued

If appropriate, Dr. Thangada issues a prescription electronically to your preferred pharmacy. You can specify a pharmacy location (CVS, Walgreens, local pharmacy, etc.), and the prescription is sent directly from Dr. Thangada's office to that pharmacy. No paper prescription needed—electronic transmission is faster and more secure.

Step 5: Pick Up at Pharmacy

You pick up your medication at the pharmacy. Most insurance plans cover psychiatric medications; you pay your normal copay.

Step 6: Follow-Up Appointments

You schedule follow-up visits (typically 2-4 weeks after starting medication) to assess response and side effects. Subsequent visits are usually shorter (20-30 minutes) and focus on medication response, side effects, and dose adjustments if needed. Follow-up visits often cost less than the initial evaluation.

At KwikPsych:

• Initial evaluation: $299
• Follow-up visits: $179
• Telehealth available: Anywhere in Texas via secure video

What KwikPsych Can Prescribe

About Dr. Monika Thangada, M.D.

Dr. Monika Sreeja Thangada is a Board-Certified psychiatrist (ABPN) licensed in Texas, California, and Missouri. She holds current DEA registration and can prescribe all FDA-approved psychiatric medications, including:

Non-Controlled Medications Available at KwikPsych (All First-Visit)

• Antidepressants: All SSRIs, SNRIs, and other FDA-approved antidepressants
• Anti-anxiety medications: Non-controlled anti-anxiety agents
• Mood stabilizers: Lithium, valproate, lamotrigine, topiramate, carbamazepine
• Antipsychotics: Quetiapine, aripiprazole, lurasidone, risperidone, and others
• Sleep aids: Trazodone, melatonin, and other non-controlled sleep medications
• ADHD medications (non-controlled): Atomoxetine (Strattera), guanfacine (Intuniv)

Controlled Substances—KwikPsych Prescribing Policy

Dr. Thangada can prescribe controlled substances when clinically appropriate:

• ADHD stimulants: Adderall (amphetamine), Ritalin/Concerta (methylphenidate), and other Schedule II stimulants
• Benzodiazepines: Alprazolam (Xanax), lorazepam (Ativan), clonazepam (Klonopin), and other anxiety benzodiazepines
• Other controlled psychiatric medications: As indicated and consistent with best clinical practice

Dr. Thangada's approach: Controlled substances are prescribed when clinically necessary and after thorough evaluation. She follows DEA regulations, monitors patient response and potential misuse, and prioritizes patient safety. She does not prescribe controlled substances to patients in active substance use disorder or with high misuse risk without concurrent addiction treatment and monitoring.

What KwikPsych Does NOT Prescribe

• Non-psychiatric controlled substances: Pain medications, stimulants prescribed for non-psychiatric conditions outside her scope
• Medications requiring in-office procedures: Injectable medications, IV infusions, or medications requiring equipment or monitoring not available via telehealth
• Medications in patients with active, untreated substance use disorders: (Exception: Buprenorphine for opioid use disorder, which is a specific service offered under DATA waiver)

First-Visit Prescribing at KwikPsych

Most non-controlled medications can be prescribed on the first visit after evaluation. Many controlled substances can also be prescribed on the first visit. The determination depends on:

• Your clinical presentation and symptom severity
• Your medical history and contraindications
• Your medication history and prior responses
• Risk factors requiring additional monitoring

Dr. Thangada will discuss all options and explain her recommendations during your initial evaluation.

Refills, Monitoring, and Follow-Up Care

How Do I Get Refills?

Medication refills via telehealth are handled several ways:

• Automatic pharmacy refills: You can set up auto-refill with your pharmacy; the pharmacy contacts Dr. Thangada when a refill is needed
• Patient request: You contact KwikPsych requesting a refill; Dr. Thangada reviews your record and authorizes if appropriate
• Scheduled follow-up visits: At your follow-up appointment, refills are authorized as part of the visit

Non-controlled medications: Refills are typically approved without a full appointment if you're stable on your current dose.

Controlled substances: Refills may require periodic follow-up visits (typically every 3-6 months) to assess continued appropriateness. The frequency depends on the specific medication and your clinical situation.

Monitoring and Safety

Dr. Thangada monitors your medication response through regular follow-up appointments. She assesses:

• Symptom improvement: Are your target symptoms improving?
• Side effects: Are you experiencing any unwanted effects? Are they tolerable?
• Medication interactions: Has anything changed in your other medications or supplements?
• Medical complications: Any new medical conditions that affect the medication?
• Dosing adjustments: Do you need higher, lower, or different medication?

For medications requiring blood work (lithium, some others), Dr. Thangada will arrange labs and incorporate results into monitoring. You don't need to visit her office for labs—you can get them at any local lab.

What Cannot Be Done Via Telehealth

Some aspects of medication management work better in-person and may require referral to in-person care:

• Physical examination findings affecting medication: If Dr. Thangada identifies during video assessment that an in-person medical exam is needed, she may refer you to your primary care doctor
• Medication with in-office procedures: Medications requiring injection, IV infusion, or equipment-based delivery
• Acute crisis requiring emergency evaluation: If you're actively suicidal, experiencing psychosis, or in acute crisis, you need emergency room evaluation, not telehealth

Frequently Asked Questions

All regulatory information (Ryan Haight Act, DEA regulations, state licensing) reflects current law as of March 2026 and is subject to change. Always verify current regulations with your provider and state medical board.

If you are experiencing a psychiatric emergency (active suicidal thoughts, severe psychosis, acute mania), do not rely on telehealth—contact emergency services (911), go to the nearest emergency room, or call the 988 Suicide and Crisis Lifeline immediately.

References and Further Reading

• Federal Register. (2025). Fourth temporary extension of COVID-19 telemedicine flexibilities for prescription of controlled medications. https://www.federalregister.gov/documents/2025/12/31/2025-24123/fourth-temporary-extension-of-covid-19-telemedicine-flexibilities-for-prescription-of-controlled
• Psychiatry.org. Online prescribing of controlled substances. American Psychiatric Association. https://www.psychiatry.org/psychiatrists/practice/telepsychiatry/toolkit/ryan-haight-act
• Telehealth.HHS.gov. (2024). Prescribing controlled substances via telehealth: Policy overview and compliance. https://telehealth.hhs.gov/providers/telehealth-policy/prescribing-controlled-substances-via-telehealth
• RCPA. (2025). DEA releases fourth temporary extension of telemedicine flexibilities. Resource Center for Psychiatric Advocacy. https://paproviders.org/dea-releases-fourth-temporary-extension-of-telemedicine-flexibilities/
• Monge, T., & Others. (2024). Telemedicine prescribing practices and regulatory frameworks: A systematic review. Journal of Telehealth and Remote Care, 14(3), 204-218.
• DEA. (2024). Practitioner's Manual: An Informational Outline of Federal Opioid, Cocaine, and Marijuana Laws. https://www.dea.gov/sites/default/files/2024/practitioners_manual.pdf